Green Thumb Industries (GTBIF) Stock Price, News & Analysis

Company Overview

Green Thumb Industries Inc. is a cannabis consumer packaged goods company and retailer headquartered in Chicago, Illinois. Founded in 2014, the company cultivates, processes, manufactures and distributes cannabis products for adult-use and medical markets in the United States.

Green Thumb’s product portfolio includes flower, pre-rolls, vaporizer products, edibles, concentrates and other cannabis products sold under brands such as RYTHM, &Shine, Good Green, incredibles and Beboe. The company also operates retail cannabis dispensaries under the RISE brand, offering products from its own portfolio and other producers where permitted by state regulations.

The company serves customers in multiple U.S. states through its cultivation and manufacturing facilities, wholesale distribution network and retail locations. Green Thumb Industries was founded by Ben Kovler, who serves as chairman and chief executive officer. Its operations are subject to the varying medical and adult-use cannabis laws and regulations of the jurisdictions in which it operates.

Key Stats

• Today's Range: $6.13 to $6.36
• 50-Day Range: $6.11 to $8.09
• 52-Week Range: $5.29 to $10.43
• Volume: 373,233 shs
• Average Volume: 690,686 shs
• Market Capitalization: $1.21 billion
• P/E Ratio: 11.50
• Dividend Yield: N/A
• Price Target: $18.00
• Consensus Rating: Moderate Buy

Green Thumb Industries Stock Analysis - MarketRank™

Green Thumb Industries scored higher than 87% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Green Thumb Industries has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and no sell ratings.

Upside Potential

Green Thumb Industries has a consensus price target of $18.00, representing about 189.9% upside from its current price of $6.21.

Amount of Analyst Coverage

Green Thumb Industries has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 3.8 / 5
• Proj. Earnings Growth: 75.00%

Earnings Growth

Earnings for Green Thumb Industries are expected to grow by 75.00% in the coming year, from $0.16 to $0.28 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Green Thumb Industries is 11.50, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.74.

Price to Earnings Ratio vs. Sector

The P/E ratio of Green Thumb Industries is 11.50, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 273.74.

Price to Book Value per Share Ratio

Green Thumb Industries has a P/B Ratio of 0.67. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.06% of the float of Green Thumb Industries has been sold short.

Short Interest Ratio / Days to Cover

Green Thumb Industries has a short interest ratio ("days to cover") of 0.06, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Green Thumb Industries has recently decreased by 97.94%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Green Thumb Industries does not currently pay a dividend.

Dividend Growth

Green Thumb Industries does not have a long track record of dividend growth.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: -0.50

News Sentiment

Green Thumb Industries has a news sentiment score of -0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.46 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Green Thumb Industries this week, compared to 2 articles on an average week.

Search Interest

28 people have searched for GTBIF on MarketBeat in the last 30 days. This is an increase of 87% compared to the previous 30 days.

MarketBeat Follows

8 people have added Green Thumb Industries to their MarketBeat watchlist in the last 30 days. This is an increase of 700% compared to the previous 30 days.

Company Ownership

• Score: 0.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Green Thumb Industries insiders have not sold or bought any company stock.

Percentage Held by Insiders

9.40% of the stock of Green Thumb Industries is held by insiders.

Percentage Held by Institutions

0.09% of the stock of Green Thumb Industries is held by institutions.

Company Calendar

• Last Earnings: 8/04/2026
• Today: 10/20/2026
• Next Earnings (Estimated): 11/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:GTBIF
• Previous Symbol: OTC:GTBIF
• CIK: 1795139
• Web: www.gtigrows.com
• Phone: 312-471-6720
• Fax: N/A
• Employees: 5,000
• Year Founded: 2014

Price Target and Rating

• Average Price Target for Green Thumb Industries: $18.00
• High Price Target: $18.00
• Low Price Target: $18.00
• Potential Upside/Downside: +189.9%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.54
• Trailing P/E Ratio: 11.50
• Forward P/E Ratio: 38.81
• P/E Growth: N/A
• Net Income: $114.15 million
• Net Margins: 10.48%
• Pretax Margin: 23.19%
• Return on Equity: 6.03%
• Return on Assets: 4.09%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.85
• Quick Ratio: 2.03

Sales & Book Value

• Annual Sales: $1.18 billion
• Price / Sales: 1.03
• Cash Flow: $1.21 per share
• Price / Cash Flow: 5.15
• Book Value: $9.24 per share
• Price / Book: 0.67

Miscellaneous

• Outstanding Shares: 195,310,000
• Free Float: 176,954,000
• Market Cap: $1.21 billion
• Optionable: Not Optionable
• Beta: 1.28